Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Blood|October 24, 2015
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemiaPhilip A Thompson, Constantine S Tam, Susan M O'Brien, et al.Cancer|July 22, 2015
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimensPhilip A Thompson, Susan M O'Brien, William G Wierda, et al.Leukemia|December 22, 2019
The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironmentEkaterina Kim, Elisa Ten Hacken, Mariela Sivina, et al.Blood|September 21, 2019
Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapyPhilip A Thompson, Jaya Srivastava, Christine Peterson, et al.Blood|September 27, 2018
A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemiaLisa S Chen, Prithviraj Bose, Nichole D Cruz, et al.Leukemia|May 3, 2023
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRDPhilip A Thompson, Michael J Keating, Alessandra Ferrajoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.Leukemia|August 8, 2022
A phase two study of high dose blinatumomab in Richter's syndromePhilip A Thompson, Xianli Jiang, Pinaki Banerjee, et al.Haematologica|March 18, 2021
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemiaKerry A Rogers, Philip A Thompson, John N Allan, et al.The Lancet. Haematology|October 24, 2022
Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trialElias Jabbour, Nicholas J Short, Nitin Jain, et al.Pageof 7